FIELD: medicine.
SUBSTANCE: what is presented is a method for prediction of haematogenic metastasis of diffuse gastric cancer by immunohistochemistry of the primary tumour preparations. For the purpose of the study, the antibodies Cyclophilin A Antibody (CypA) clone NBP 1-54388 at the working dilution of 1:1200. If there is a positive CypA cytoplasmic expression in the primary tumour cells, a low risk of haematogenic metastasis is predicted.
EFFECT: invention enables predicting the low risk of haematogenic metastasis accompanying diffuse gastric cancer and avoiding excessive adjuvant therapy.
2 dwg, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING HEMATOGENOUS METASTASES IN INTESTINAL TYPE OF STOMACH CANCER | 2011 |
|
RU2470308C1 |
| METHOD FOR PREDICTION OF ONSET OF HEMATOGENOUS METASTASES ACCOMPANYING SQUAMOUS CELL LUNG CANCER | 2012 |
|
RU2489718C1 |
| METHOD FOR PREDICTION OF HAEMATOGENOUS METASTASIS IN TRIPLE NEGATIVE INVASIVE NON-SPECIFIC BREAST CARCINOMA | 2014 |
|
RU2558863C1 |
| PROGNOSIS METHOD FOR DISEASE PROGRESSION IN PATIENTS WITH GASTROINTESTINAL CANCER AFTER TREATMENT | 2021 |
|
RU2758079C2 |
| METHOD FOR PREDICTION OF LYMPHATIC CANCER SPREAD ACCOMPANYING NON-SPECIFIC BREAST CARCINOMA | 2014 |
|
RU2566732C1 |
| METHOD FOR EVALUATING THE DEGREE OF RISK OF ADVERSE EVALUATION OF DISEASE IN PATIENTS WITH GASTRIC CANCER | 2016 |
|
RU2662085C1 |
| METHOD FOR PREDICTION OF DEVELOPING HAEMATOGENOUS METASTASES FOLLOWING COMBINED TREATMENT OF KIDNEY CANCER | 2013 |
|
RU2528100C1 |
| METHOD FOR PREDICTING THE DEGREE OF RISK OF DEVELOPING HEMATOGENOUS METASTASES IN INVASIVE CARCINOMA OF A NON-SPECIFIC TYPE OF MAMMARY GLAND BASED ON THE ASSESSMENT OF THE EXPRESSION OF LIMCH1 PROTEIN | 2020 |
|
RU2755242C1 |
| METHOD FOR PREDICTION OF LYMPHATIC CANCER SPREAD ACCOMPANIED BY INVASIVE NONSPECIFIC TRIPLE-NEGATIVE BREAST CANCER | 2014 |
|
RU2558860C1 |
| METHOD OF PREDICTING HEMATOGENOUS METASTASIS OF COLON CANCER AFTER COMBINED TREATMENT | 2023 |
|
RU2797845C1 |
